Cart
sales@molnova.com
Emicizumab
CAS No. 1610943-06-0
Emicizumab( —— )
Catalog No. M36904 CAS No. 1610943-06-0
Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 3952 | In Stock |
|
| 10MG | 5339 | In Stock |
|
| 25MG | 7942 | In Stock |
|
| 50MG | 10416 | In Stock |
|
| 100MG | 14136 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmicizumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
-
DescriptionEmicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research.
-
In Vitro——
-
In VivoAnimal Model:FVIII-deficient mice Dosage:1.5-10 mg/kg Administration:IV, 24 hours before tail-clip bleeding was performed Result:Significantly reduced blood loss in a tail-clip-bleeding model using FVIII-deficient mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1610943-06-0
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ferrière S, et al. A hemophilia A mouse model for the in vivo assessment of emicizumab function. Blood. 2020 Aug 6;136(6):740-748.?
molnova catalog
related products
-
GNE-1858
GNE-1858 is an ATP-competitive hematopoietic progenitor kinase-1 (HPK1) inhibitor (IC50s of 1.9 nM, 1.9 nM, and 4.5 nM for wild-type and the active mimetic mutants HPK1-TSEE and HPK1-SA).
-
R(+)-Gomisin M1
Gomisin M1 ((±)-Gomisin M1) is a potent anti-HIV agent with an EC50 of <0.65 μM.
-
Nafetolol
Nafetolol (K 5407) is a biochemical reagent that can be used to synthesize other compounds.
